NO984836L - Substituerte benzylaminer og deres anvendelse for behandling av depresjon - Google Patents

Substituerte benzylaminer og deres anvendelse for behandling av depresjon

Info

Publication number
NO984836L
NO984836L NO984836A NO984836A NO984836L NO 984836 L NO984836 L NO 984836L NO 984836 A NO984836 A NO 984836A NO 984836 A NO984836 A NO 984836A NO 984836 L NO984836 L NO 984836L
Authority
NO
Norway
Prior art keywords
depression
treatment
substituted benzylamines
benzylamines
substituted
Prior art date
Application number
NO984836A
Other languages
English (en)
Other versions
NO984836D0 (no
NO311976B1 (no
Inventor
Dirk Casimir Maria Leysen
Gerardus Stephanus Franc Ruigt
Joannes Theodorus Mari Linders
Fredericus Antonius Dijcks
Simon James Anthony Grove
Duncan Robertson Rae
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO984836D0 publication Critical patent/NO984836D0/no
Publication of NO984836L publication Critical patent/NO984836L/no
Publication of NO311976B1 publication Critical patent/NO311976B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
NO19984836A 1996-04-19 1998-10-16 Substituerte benzylaminer, deres anvendelse samt farmasöytisk formulering NO311976B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201065 1996-04-19
PCT/EP1997/001904 WO1997040027A1 (en) 1996-04-19 1997-04-15 Substituted benzylamines and their use for the treatment of depression

Publications (3)

Publication Number Publication Date
NO984836D0 NO984836D0 (no) 1998-10-16
NO984836L true NO984836L (no) 1998-12-16
NO311976B1 NO311976B1 (no) 2002-02-25

Family

ID=8223896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984836A NO311976B1 (no) 1996-04-19 1998-10-16 Substituerte benzylaminer, deres anvendelse samt farmasöytisk formulering

Country Status (25)

Country Link
EP (1) EP0898566B1 (no)
JP (1) JP4008033B2 (no)
CN (1) CN1139580C (no)
AR (1) AR006719A1 (no)
AT (1) ATE227278T1 (no)
AU (1) AU725847B2 (no)
BR (1) BR9708790A (no)
CA (1) CA2251820C (no)
CZ (1) CZ295747B6 (no)
DE (1) DE69716896T2 (no)
DK (1) DK0898566T3 (no)
ES (1) ES2186888T3 (no)
HK (1) HK1018271A1 (no)
HU (1) HU224637B1 (no)
ID (1) ID17723A (no)
IL (1) IL120669A (no)
NO (1) NO311976B1 (no)
NZ (1) NZ332334A (no)
PL (1) PL192561B1 (no)
PT (1) PT898566E (no)
RU (1) RU2179553C2 (no)
TR (1) TR199802104T2 (no)
TW (1) TW498070B (no)
WO (1) WO1997040027A1 (no)
ZA (1) ZA973209B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080773A (en) * 1997-10-14 2000-06-27 Akzo Nobel, N.V. Benzylamine derivatives which are useful in treating psychiatric disorders
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
PT1216244E (pt) * 1999-09-14 2003-12-31 Aventis Pharma Inc Derivados de benzisoxazolil- piridoisoxazolil- e benztienil-fenoxi uteis como antagonistas d4
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
GB0321538D0 (en) 2003-09-13 2003-10-15 Glaxo Group Ltd Therapeutically useful compounds
EP1925305A1 (en) * 2006-10-23 2008-05-28 N.V. Organon Ih channel inhibitors for the promotion of wakefulness
SG171928A1 (en) 2008-12-24 2011-07-28 Astrazeneca Ab Ethanamine compounds and their use for treating depression
US8637551B2 (en) 2009-07-07 2014-01-28 Merck Sharp & Dohme B.V. 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives
CN102942464B (zh) * 2012-12-06 2015-04-08 西北师范大学 化合物1-(2-卤苯基)-3-甲基-丁酮-1的合成方法
CN112300061B (zh) * 2020-10-06 2022-02-18 大连理工大学 一种含氮杂环二芳酮化合物的制备方法
GB202103012D0 (en) 2021-03-03 2021-04-14 King S College London Compounds
GB202103017D0 (en) 2021-03-03 2021-04-14 King S College London Compounds
GB202103008D0 (en) 2021-03-03 2021-04-14 King S College London Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980365A (en) * 1987-07-13 1990-12-25 Hoechst-Roussel Pharmaceuticals Inc. N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
HUP9901434A2 (hu) 1999-08-30
AU2387097A (en) 1997-11-12
ES2186888T3 (es) 2003-05-16
TW498070B (en) 2002-08-11
JP2000508672A (ja) 2000-07-11
HU224637B1 (hu) 2005-12-28
IL120669A (en) 2001-04-30
EP0898566B1 (en) 2002-11-06
HUP9901434A3 (en) 2001-11-28
DE69716896D1 (de) 2002-12-12
HK1018271A1 (en) 1999-12-17
AU725847B2 (en) 2000-10-19
WO1997040027A1 (en) 1997-10-30
DE69716896T2 (de) 2003-07-24
IL120669A0 (en) 1997-08-14
PL329348A1 (en) 1999-03-29
PL192561B1 (pl) 2006-11-30
EP0898566A1 (en) 1999-03-03
TR199802104T2 (xx) 2000-09-21
JP4008033B2 (ja) 2007-11-14
CN1219169A (zh) 1999-06-09
CN1139580C (zh) 2004-02-25
CA2251820C (en) 2007-03-27
ATE227278T1 (de) 2002-11-15
NO984836D0 (no) 1998-10-16
AR006719A1 (es) 1999-09-08
BR9708790A (pt) 1999-08-03
RU2179553C2 (ru) 2002-02-20
ZA973209B (en) 1997-11-20
DK0898566T3 (da) 2003-03-03
CZ295747B6 (cs) 2005-10-12
CZ334998A3 (cs) 1999-06-16
CA2251820A1 (en) 1997-10-30
ID17723A (id) 1998-01-22
PT898566E (pt) 2003-03-31
NZ332334A (en) 2000-06-23
NO311976B1 (no) 2002-02-25

Similar Documents

Publication Publication Date Title
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
NO964958D0 (no) Aluminium-scandiumlegeringer og deres anvendelse
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO942193D0 (no) Metallocener og fremgangsmåte til deres fremstilling og bruk
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
NO985196D0 (no) Dispergerbare makromolekylblandinger og fremgangsmÕter for deres fremstilling og anvendelse
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
NO972983D0 (no) Sulfonamider og deres anvendelse
IS4481A (is) Díhýdrópyramídín og notkun þeirra
DK0621042T3 (da) Kirurgisk forbinding og adhæsivsammensætning dertil
NO983235D0 (no) Fikstur og protese innbefattende samme
IS4731A (is) Kínólín og kínazólín efnasambönd nytsamleg í meðferð
NO973338D0 (no) N-(4-aryl-tiazol-2-yl)-sulfonamid-derivater og deres anvendelse
DK0804078T3 (da) Sammensætning og anvendelse deraf
NO984836D0 (no) Substituerte benzylaminer og deres anvendelse for behandling av depresjon
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
NO975020D0 (no) Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi
NO20020031D0 (no) Dihydrobenzodiazepiner og deres anvendelse ved behandling av dyslipidemi
CY2482B1 (en) Paroxetine in treatment of depression.
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
ZA981781B (en) The use of levobupivacaine in treating migraine
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
NO992310D0 (no) Inhibitorer og deres anvendelse i oljer

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees